Skip to main content

Highland Medical nationally recognized for its commitment to improve cardiovascular health

American Heart Association gold badges with red ribbons for Blood Pressure and Type 2 Diabetes.Nyack, NY, November 12, 2026 -- Highland Medical has received two American Heart Association outpatient program achievement awards in recognition for its commitment to reducing the risk of heart disease and stroke by improving Type 2 diabetes and blood pressure management. The awards recognize a commitment to following the latest evidence- and science-based care guidelines.

Nearly half of all adults in the U.S. have some form of cardiovascular disease, including heart attack, stroke or heart failure. Type 2 diabetes and uncontrolled high blood pressure are leading risk factors for cardiovascular disease, but with timely diagnosis, research-based treatment and education, these conditions can be managed.

We are proud to be recognized by the American Heart Association for our focus on Type 2 diabetes and high blood pressure management and care, said Yadira Castro, associate vice president at Highland Medical. These programs help us to put the science of the latest science-backed guidelines to work improving the lives of our patients.

The outpatient achievement award programs put the unparalleled expertise of the American Heart Association to work for health care organizations nationwide, helping ensure the care provided to patients is aligned with the latest evidence- and research-based guidelines. As a participant in the Target: BP, and Target: Type 2 Diabetes programs, Highland Medical was recognized after demonstrating how their organization has committed to improving risk factor management for patients.

This year, Highland Medical received these achievement awards:

  • The American Heart Association’s Target: Type 2 Diabetes℠ Gold+
  • Target: BP™ Gold+ recognition presented by the American Heart Association.

Heart disease and stroke remain the leading causes of death for Americans, and addressing Type 2 diabetes and blood pressure management is key for better cardiovascular health, said Kevin Hwang, M.D., volunteer chair of the American Heart Association's Outpatient Quality Improvement Advisory Group. The American Heart Association is pleased to recognize Highland Medical for its commitment to managing patient risk factors related to high blood pressure and Type 2 diabetes.

About Highland Medical
Highland Medical is a comprehensive network of medical practices staffed by some of the area’s finest physicians, who offer high-quality, patient-centered, and cost-effective care, and are affiliated with Montefiore Nyack Hospital. Practices include primary care; family practice medicine; breast and women’s health; cardiology; endocrinology; hematology/oncology; gastroenterology, nephrology; neurology; obstetrics/gynecology; pulmonary, psychiatry, surgery, and wound care. To learn more, visit https://www.highlandmedical.co and follow us on Facebook, Instagram, and LinkedIn.

About Target: BPTM
Target: BP™ is a national initiative to reduce the number of Americans who suffer from heart attacks and strokes each year by urging physician practices, health systems and patients to prioritize hypertension control. The initiative aims to help health care organizations improve blood pressure control rates using evidence-based protocols, tools and resources and recognizes organizations that treat patients with hypertension for achieving blood pressure control rates within the populations they serve.

About Target: Type 2 DiabetesSM
The American Heart Association, the world’s leading voluntary organization dedicated to building longer, healthier lives, created Target: Type 2 Diabetes to raise awareness and understanding of the link between diabetes and cardiovascular disease among patients, caregivers and health care professionals as well as empower patients and caregivers to better manage risk factors.

The Target: Type 2 Diabetes program supports physicians and care teams by offering access to the latest research, tools and resources to provide the most up-to-date cardiovascular and Type 2 diabetes management and treatment.

Release Date